A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

Current treatments for chronic hand eczema (CHE) generally fall into two buckets: Either they battle inflammation but lead to ...

If your drug trials don't succeed, try again with another drug — and raise more money. That's $RAPT's plan as it targets food ...

The clinical trial is for a new drug for people with moderate to severe eczema, the NHS trust says The first UK patient has been recruited to take part in a clinical trial for a new drug for ...

Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.

“Red light therapy is an energy-based modality that uses specific wavelengths of red and near-infrared light (typically ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

Shares of QTTB fall after its experimental autoimmune disease drug failed to meet the primary endpoint in a mid-stage study for eczema.